UK markets close in 4 hours 20 minutes

MERCK Kommanditgesellschaft auf Aktien (0O14.IL)

IOB - IOB Delayed price. Currency in EUR
Add to watchlist
169.80-0.10 (-0.06%)
As of 11:38AM BST. Market open.
Full screen
Previous close169.90
Bid168.35 x 0
Ask171.85 x 0
Day's range168.70 - 170.50
52-week range153.10 - 202.30
Avg. volume141,445
Market cap73.496B
Beta (5Y monthly)0.64
PE ratio (TTM)20.99
EPS (TTM)8.09
Earnings dateN/A
Forward dividend & yield2.20 (1.34%)
Ex-dividend date02 May 2023
1y target estN/A
  • Reuters

    Merck KGaA expects 2023 profit to slip as COVID demand wanes

    Germany's Merck KGaA on Thursday predicted 2023 earnings would slip due to a decline at its electronic chemicals unit and a drop in COVID-related demand for its lab supplies from drug and vaccine makers. For 2023 earnings before interest, taxes, depreciation and amortisation (EBITDA), adjusted for one-offs, the company "assumes a moderate decline to an about stable development", before any currency swings, it said in a statement. Negative foreign exchange effects would likely be an additional drag of between 1% and 4%, according to the maker of pharmaceuticals, lab equipment and specialty chemicals.

  • Zacks

    Bears are Losing Control Over Merck KGaA (MKGAF), Here's Why It's a 'Buy' Now

    Merck KGaA (MKGAF) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.